Latest filing published 11 Jun 2021 for Pacira BioSciences, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Donald C. Manning, listed as senior executive, appears in our data through filings on Pacira BioSciences, Inc. shares, published by SEC (Form 4). In total, 3 filings cover trades dated from 2 June 2021 to 9 June 2021.
Every open-market trade on record is a sale: 2 sales worth €252k. The rest of the record consists of 1 share grant.
On 11 June 2021 came the latest disclosure, a share grant in Pacira BioSciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations